Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | JAK1 | P23458 | 1/20 | 0.47 |
| ▸ | KDM1A | O60341 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 4/20 | 0.43 |
| ▸ | NPFFR1 | Q9GZQ6 | 1/20 | 0.43 |
| ▸ | NPFFR2 | Q9Y5X5 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.42 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | EIF2AK4 | Q9P2K8 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.41 |
| ▸ | CCR5 | P51681 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1552482 | 1.00 | KMT2A (0.60) | KMT2AL3MBTL1JAK1KDM1AMAOB | |
| SCHEMBL19051699 | 1.00 | KMT2A (0.60) | KMT2AL3MBTL1JAK1KDM1AMAOB | |
| SCHEMBL30404117 | 1.00 | KMT2A (0.60) | KMT2AL3MBTL1JAK1KDM1AMAOB | |
| SCHEMBL1552484 | 1.00 | KMT2A (0.60) | KMT2AL3MBTL1JAK1KDM1AMAOB | |
| SCHEMBL2378151 | 1.00 | KMT2A (0.60) | KMT2AL3MBTL1JAK1KDM1AMAOB | |
| SCHEMBL9929564 | 1.00 | KMT2A (0.60) | KMT2AL3MBTL1JAK1KDM1AMAOB | |
| SCHEMBL17304781 | 0.93 | KMT2A (0.65) | KMT2AL3MBTL1JAK1KDM1AMAOB | |
| SCHEMBL1815532 | 0.90 | KMT2A (0.65) | KMT2AL3MBTL1JAK1KDM1AMAOB | |
| SCHEMBL25263326 | 0.88 | KMT2A (0.60) | KMT2AL3MBTL1JAK1KDM1AMAOB | |
| SCHEMBL21166304 | 0.88 | KMT2A (0.60) | KMT2AL3MBTL1JAK1KDM1AMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010002415-A1 | TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA INFECTION | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2010-01-07 | — | — | WO | disclosed |
| WO-2010002965-A2 | PNEUMONIA TREATMENT | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2010-01-07 | — | — | WO | disclosed |
| WO-2009023473-A2 | ANTIMICROBIAL PARENTERAL FORMULATION | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2009-02-19 | — | — | WO | disclosed |
| US-20090042932-A1 | ANTIMICROBIAL PARENTERAL FORMULATION | TAIGEN BIOTECHNOLOGY COMPANY LTD. (TW) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042932-A1 | ANTIMICROBIAL PARENTERAL FORMULATION | SLC10A2, ABCB11, SLC47A1 | KMT2A 4823/4885L3MBTL1 3571/4885JAK1 544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.